Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinoma

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1123-1128

  Mohammadi Asl, Javad ^a   Larijani, Bagher ^a   Khorgami, Zhamak ^b   Tavangar, Seyed Mohammad ^b   Haghpanah, Vahid ^a   Kheirollahi, Majid ^a   Mehdipour, Parvin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Methylation; P16; Papillary thyroid carcinoma; RAR 2; RASSF1A; TSHR

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; THYROTROPIN RECEPTOR;

ADULT; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, PAPILLARY; DNA METHYLATION; FEMALE; GENES, P16; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROTROPIN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84655165070     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9587-z     Document Type: Article

References (24)

1. EL Mazzaferri 1993 Management of a solitary thyroid nodule N Engl J Med 328 8 553 559
2. A Belfiore GL La Rosa 2001 Fine-needle aspiration biopsy of the thyroid Endocrinol Metab Clin North Am 30 2 361 400
3. TV McCaffrey 2000 Evaluation of the thyroid nodule Cancer Control 7 3 223 228
4. V600E mutation in iranian patients with papillary thyroid carcinoma: a single-center study J Appl Sci 9 19 3593 3597
5. JA Smith CY Fan C Zou D Bodenner MS Kokoska 2007 Methylation status of genes in papillary thyroid carcinoma Arch Otolaryngol Head Neck Surg 133 10 1006 1011
6. M Fryknas U Wickenberg-Bolin H Goransson MG Gustafsson T Foukakis JJ Lee 2006 Molecular markers for discrimination of benign and malignant follicular thyroid tumors Tumor Biol 27 4 211 220
7. V Haghpanah P Shooshtarizadeh R Heshmat B Larijani SM Tavangar 2006 Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma Appl Immunohistochem Mol Morphol 14 4 422 425
8. JG Herman 2005 Epigenetic changes in cancer and preneoplasia Cold Spring Harb Symp Quant Biol 70 329 333
9. KD Robertson PA Jones 1999 Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus Oncogene 18 26 3810 3820
10. AK Lam CY Lo P Leung BH Lang WF Chan JM Luk 2007 Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma Ann Surg Oncol 14 5 1772 1779
11. C Boltze S Zack C Quednow S Bettge A Roessner R Schneider-Stock 2003 Hypermethylation of the CDKN2/p16INK4A promotor in thyroid carcinogenesis Pathol Res Pract 199 6 399 404
12. MO Hoque E Rosenbaum WH Westra M Xing P Ladenson MA Zeiger 2005 Quantitative assessment of promoter methylation profiles in thyroid neoplasms J Clin Endocrinol Metab 90 7 4011 4018
13. U Schagdarsurengin O Gimm H Dralle C Hoang-Vu R Dammann 2006 CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma Thyroid 16 7 633 642
14. P Kopp 2001 The TSH receptor and its role in thyroid disease Cell Mol Life Sci 58 9 1301 1322
15. M Xing H Usadel Y Cohen Y Tokumaru Z Guo WB Westra 2003 Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing Cancer Res 63 9 2316 2321
16. L Shivakumar J Minna T Sakamaki R Pestell MA White 2002 The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation Mol Cell Biol 22 12 4309 4318
17. S Tommasi R Dammann Z Zhang Y Wang L Liu WM Tsark 2005 Tumor susceptibility of Rassf1a knockout mice Cancer Res 65 1 92 98
18. U Schagdarsurengin O Gimm C Hoang-Vu H Dralle GP Pfeifer R Dammann 2002 Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma Cancer Res 62 13 3698 3701
19. N Nakamura JA Carney L Jin S Kajita J Pallares H Zhang 2005 RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors Lab Invest 85 9 1065 1075
20. DR Soprano P Qin KJ Soprano 2004 Retinoic acid receptors and cancers Annu Rev Nutr 24 201 221
21. Z Xiong PW Laird 1997 COBRA: a sensitive and quantitative DNA methylation assay Nucleic Acids Res 25 12 2532 2534
22. N Konishi M Nakamura M Kishi M Nishimine E Ishida K Shimada 2002 Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas Am J Pathol 160 4 1207 1214
23. S Hu M Ewertz RP Tufano M Brait AL Carvalho D Liu 2006 Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer J Clin Endocrinol Metab 91 1 98 104
24. E Ishida M Nakamura K Shimada T Higuchi K Takatsu K Yane 2007 DNA hypermethylation status of multiple genes in papillary thyroid carcinomas Pathobiology 74 6 344 352